# Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography

Study · id `cardio:ct-nct01869062` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01869062](<https://clinicaltrials.gov/study/NCT01869062>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01869062

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 348 participants.

## Technical summary

Registry record NCT01869062. Randomized; double masking; primary purpose other. Start 2013-06 (actual); primary completion 2016-05-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose other
- Phase: Not applicable
- Enrolled: 348 participants (enrolled count; ClinicalTrials.gov record NCT01869062, source copy `cardio:ctgov-nct01869062-2019-03-22`, retrieved 2026-10-26)
- Started: 2013-06 (actual) (ClinicalTrials.gov record NCT01869062, source copy `cardio:ctgov-nct01869062-2019-03-22`, retrieved 2026-10-26)
- Primary completion: 2016-05-19 (actual) (ClinicalTrials.gov record NCT01869062, source copy `cardio:ctgov-nct01869062-2019-03-22`, retrieved 2026-10-26)
- Completion: 2016-05-19 (actual) (ClinicalTrials.gov record NCT01869062, source copy `cardio:ctgov-nct01869062-2019-03-22`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01869062, source copy `cardio:ctgov-nct01869062-2019-03-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01869062-2019-03-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography
- Acronym: SonR-ECHO
- Condition: Heart Failure
- Intervention (Device): SonR CRT Optimization 'On'
- Intervention (Device): SonR CRT Optimization 'Off'
- Lead sponsor: MicroPort CRM
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: MicroPort CRM (`cardio:org-microport-crm`)

## Provenance

Content hash: 78c4dc10baa6ca255780cecba6292d18b488d7b92aec0e4aa2616d9da7cb548a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
